人福医药集团股份公司 2025 年第三季度报告 证券代码：600079 证券简称：人福医药 人福医药集团股份公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 公司董事会及董事、高级管理人员保证季度报告内容的真实、准确、完整，不存在虚假记载、误 导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息 的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、主要财务数据 （一） 主要会计数据和财务指标 1 / 17 单位：元 币种：人民币 项目 本报告期 本报告期比 上年同期增 减变动幅度 (%) 年初至报告期末 年初至报告期 末比上年同期 增减变动幅度 (%) 营业收入 5,819,434,372.57 -7.36 17,883,352,478.34 -6.58 利润总额 842,435,083.37 3.55 2,631,660,616.27 1.65 归属于上市公司股东的 净利润 533,9 ...

Financial Performance - The company's operating revenue for the third quarter reached ¥903,380,749.29, an increase of 7.97% compared to the same period last year[4] - The total profit for the quarter was ¥64,015,670.38, a decrease of 24.65% year-over-year[4] - The net profit attributable to shareholders was ¥62,096,410.51, down 24.09% from the previous year[4] - The net profit after deducting non-recurring gains and losses decreased by 31.78% to ¥52,107,833.09[6] - Total operating revenue for the first three quarters of 2025 reached ¥2,681,295,266.32, an increase of 8.05% compared to ¥2,481,737,531.76 in the same period of 2024[20] - Net profit for the first three quarters of 2025 was ¥237,484,834.54, a decrease of 3.99% from ¥246,969,977.70 in the previous year[21] - The company recorded a total profit of CNY 262,267,316.47 for the first three quarters of 2025, compared to CNY 282,151,922.53 in the same period of 2024, reflecting a decrease of 7.1%[30] Cash Flow and Liquidity - The net cash flow from operating activities for the year-to-date increased by 32.55% to ¥531,867,325.58, primarily due to increased sales receipts and government subsidies[5] - Operating cash inflow for the first three quarters of 2025 reached CNY 2,803,123,369.28, an increase of 12.4% compared to CNY 2,493,394,846.45 in the same period of 2024[23] - The net cash flow from operating activities for the first three quarters of 2025 was CNY 264,775,462.84, down 30.1% from CNY 378,667,166.69 in the same period of 2024[32] - The company reported a net increase in cash and cash equivalents of CNY 921,081,047.02 for the first three quarters of 2025, compared to a decrease of CNY -289,153,653.89 in the previous year[25] - Total cash and cash equivalents at the end of September 2025 amounted to CNY 2,057,897,669.78, compared to CNY 1,177,513,617.39 at the end of 2024, reflecting a significant increase[25] Assets and Liabilities - The total assets at the end of the reporting period were ¥8,197,132,494.24, reflecting a year-over-year increase of 13.31%[5] - The company's current assets reached CNY 5,884,475,777.74, compared to CNY 5,260,390,177.68 in the previous year, indicating a year-over-year increase of about 11.8%[17] - The company's total liabilities rose to ¥3,577,376,466.59, compared to ¥2,820,506,454.72 in the previous year, reflecting a significant increase of 27%[19] - Total liabilities increased to CNY 3,165,952,790.68 from CNY 2,612,027,820.84, reflecting a rise of 21.2%[28] - The company's total cash inflow from investment activities in the first three quarters of 2025 was CNY 1,040,430,117.36, up from CNY 562,355,000.36 in the same period of 2024[32] Shareholder and Ownership Structure - The company reported no changes in the shareholding structure of the top 10 shareholders, maintaining stability in ownership[15] - The company has not engaged in any financing or margin trading activities during the reporting period, ensuring a conservative financial approach[15] Research and Development - Research and development expenses for the first three quarters were ¥128,102,075.75, slightly down from ¥128,440,981.60 in the same period last year[20] - Research and development expenses for the first three quarters of 2025 were CNY 120,530,765.51, slightly down from CNY 124,027,839.48 in the first three quarters of 2024[29] Other Financial Metrics - The weighted average return on equity decreased to 1.36%, down 27.66 percentage points compared to the previous year[5] - Basic and diluted earnings per share for the period were both ¥1.9599, down from ¥2.0382 in the previous year[22] - Other comprehensive income after tax amounted to ¥98,934.60, compared to a loss of -¥2,598.53 in the same period last year[21] - The company reported a financial expense of -¥50,676,773.46, compared to -¥16,686,228.64 in the previous year, indicating a significant increase in financial costs[20]

Revenue and Profitability - The company's revenue for Q3 2025 was ¥305,842,291.31, a decrease of 27.95% compared to the same period last year[5] - Net profit attributable to shareholders for Q3 2025 was ¥13,414,212.15, an increase of 80.77% year-on-year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥187,810.37, a decline of 105.76% compared to the previous year[5] - Total operating revenue for the current period was ¥1,093,873,651.93, a decrease of 9.9% from ¥1,214,136,418.29 in the previous period[17] - Net profit for the current period was ¥58,824,153.56, a decline of 32.6% compared to ¥87,272,527.89 in the previous period[19] Earnings Per Share - Basic and diluted earnings per share for Q3 2025 were both ¥0.11, an increase of 87.87% year-on-year[5] - Basic earnings per share for the current period was ¥0.38, down from ¥0.59 in the previous period[19] - The diluted earnings per share for the current period is 0.38, compared to 0.59 in the previous period[20] Cash Flow - The operating cash flow net amount for the year-to-date period reached ¥206,751,560.94, a significant increase of 796.38%[5] - The net cash flow from operating activities for the first nine months of 2025 was significantly improved, rising from ¥23,065,087.79 to ¥206,751,560.94[8] - Cash inflow from operating activities totaled ¥1,526,507,831.65, an increase of 37.4% from ¥1,110,538,853.79 in the previous period[20] - The net cash flow from operating activities is ¥206,751,560.94, significantly up from ¥23,065,087.79 in the previous period[20] - Cash outflow from investment activities reached ¥2,538,798,875.08, compared to ¥1,944,148,050.89 in the previous period, resulting in a net cash flow from investment activities of -¥556,260,092.62[21] - Cash inflow from financing activities was ¥707,100,913.26, an increase from ¥672,465,520.70 in the previous period[21] - The net cash flow from financing activities improved to ¥286,998,545.55 from ¥82,248,861.49 in the previous period[21] Assets and Liabilities - Total assets at the end of Q3 2025 were ¥3,494,554,578.48, reflecting a 0.99% increase from the end of the previous year[5] - The company's equity attributable to shareholders increased by 1.86% to ¥2,161,545,266.30 compared to the end of the previous year[5] - The company's total assets increased to ¥3,494,554,578.48, up from ¥3,460,279,665.56, reflecting a growth of 1.0%[17] - Total liabilities decreased to ¥1,234,422,840.80 from ¥1,252,432,403.36, a reduction of 1.4%[17] Shareholder Information - The total number of common shareholders at the end of the reporting period was 8,744, with no preferred shareholders having restored voting rights[9] - Jiangsu Shangkun Biological Equipment Co., Ltd. held 29.08% of shares, amounting to 34,890,248 shares, making it the largest shareholder[9] - The company reported a total of 70,347,000 restricted shares at the beginning of the period, with 24,342,564 shares released during the period[12] Investment and Expenses - The company experienced a 23.46% increase in fixed assets, amounting to ¥742,945,709.09 as of September 30, 2025[8] - The fixed assets increased to 742,945,709.09 from 601,782,026.25, reflecting ongoing investments in property and equipment[15] - The company’s long-term equity investments were reported at 40,000,000.00, indicating a strategic focus on long-term growth[15] - Research and development expenses were ¥51,065,297.06, a decrease of 11.3% from ¥57,588,177.15[17] - The company reported an investment income of ¥14,180,211.34, an increase from ¥8,007,368.21 in the previous period[19] Cash and Equivalents - The cash and cash equivalents at the end of the period were 709,614,994.19, down from 880,380,086.42 at the beginning of the period[15] - The total current assets decreased to 2,341,881,763.87 from 2,517,288,396.14, indicating a decline in liquidity[15] - The ending balance of cash and cash equivalents is ¥543,986,703.65, slightly up from ¥543,223,872.96 in the previous period[21] - The company received ¥17,268,358.56 in tax refunds, up from ¥8,469,096.83 in the previous period[20] - The company reported cash received from sales of goods and services of ¥1,224,286,913.99, an increase from ¥1,063,079,018.45 in the previous period[20] Comprehensive Income - Other comprehensive income after tax was -¥45,091.69, compared to -¥792,488.54 in the previous period[19]

Financial Performance - The company's operating revenue for the third quarter was ¥7,151,323,426.57, a decrease of 12.46% compared to the same period last year[4] - The total profit for the quarter was ¥167,770,895.98, reflecting a decline of 3.43% year-over-year[4] - The net profit attributable to shareholders was ¥114,593,849.59, down 15.19% from the previous year[4] - The net profit after deducting non-recurring gains and losses was ¥103,815,414.81, a decrease of 22.47% compared to the same period last year[4] - Basic earnings per share for the first three quarters of 2025 is CNY 0.21, down from CNY 0.24 in the same period of 2024[23] - Net profit for the first three quarters of 2025 was approximately $537.90 million, a decrease of 10% from $597.26 million in 2024[22] - Operating profit for the first three quarters of 2025 was approximately $629.26 million, down 8.84% from $690.46 million in 2024[22] - Net profit for the first three quarters of 2025 decreased to CNY 296,318,494.16, down from CNY 347,717,680.91 in 2024, representing a decline of approximately 14.8%[31] - Operating profit for the first three quarters of 2025 was CNY 295,852,661.33, compared to CNY 347,717,680.91 in 2024, indicating a decrease of about 14.9%[31] Cash Flow - The cash flow from operating activities showed a significant decline of 258.06%, with a net amount of -¥698,394,041.25 for the year-to-date period[5][9] - The company’s cash flow from operating activities showed a positive trend, indicating effective cash management strategies[22] - Net cash flow from operating activities for the first three quarters of 2025 is negative CNY 698,394,041.25, compared to positive CNY 441,862,415.72 in the same period of 2024[24] - Total cash inflow from operating activities decreased to CNY 20,334,689,704.51 in 2025 from CNY 22,820,446,713.44 in 2024, a decline of approximately 10.9%[24] - Cash outflow from operating activities also decreased to CNY 21,033,083,745.76 in 2025 from CNY 22,378,584,297.72 in 2024, a decline of about 6%[24] - Cash flow from operating activities for the first three quarters of 2025 was negative at CNY -14,400,704.20, an improvement from CNY -16,079,402.58 in 2024[34] - Cash flow from investing activities generated CNY 306,555,404.66 in the first three quarters of 2025, compared to CNY 373,178,713.71 in 2024, reflecting a decrease of approximately 17.8%[35] - Cash flow from financing activities resulted in a net outflow of CNY -223,730,142.91 in the first three quarters of 2025, compared to CNY -288,848,867.25 in 2024, showing an improvement[35] Assets and Liabilities - The total assets at the end of the reporting period were ¥33,442,335,643.12, an increase of 2.78% from the end of the previous year[5] - The company's total assets as of the latest reporting period were approximately $33.44 billion, an increase from $32.54 billion in the previous year[18] - Total liabilities increased to approximately $23.98 billion from $23.21 billion year-over-year[18] - The total assets as of September 30, 2025, amount to CNY 7,204,294,555.83, an increase from CNY 7,119,715,066.29 at the end of 2024[29] - The total liabilities as of September 30, 2025, are CNY 513,805,823.48, compared to CNY 425,422,450.67 at the end of 2024[29] Shareholder Information - The total number of common shareholders at the end of the reporting period was 139,868[11] - The largest shareholder, Wuxi Industrial Development Group Co., Ltd., holds 640,624,856 shares, accounting for 30.63% of the total shares[11] - The equity attributable to shareholders increased to ¥8,656,601,290.37, up 1.76% from the previous year-end[5] - The company's equity attributable to shareholders was approximately $8.66 billion, up from $8.51 billion in the previous year[18] Investments and Expenses - The company has invested RMB 10,800 million in the Qiyuan Qixin Equity Investment Fund, representing 9% of the total capital[14] - Research and development expenses for the first three quarters of 2025 were approximately $565.59 million, slightly down from $588.08 million in 2024[21] - Management expenses increased to CNY 18,439,450.59 in the first three quarters of 2025, up from CNY 14,550,921.65 in 2024, marking an increase of approximately 26.5%[31] - Interest expenses for the first three quarters of 2025 were CNY 10,408,554.78, down from CNY 12,027,752.05 in 2024, indicating a decrease of about 13.5%[31] Share Repurchase - The company plans to repurchase shares with a total fund of no less than RMB 100 million and no more than RMB 120 million, with a maximum repurchase price of RMB 10.28 per share[13] - A total of 14,648,000 shares were repurchased at an average price of RMB 6.83 per share, totaling RMB 100,017,900[14]

Financial Performance - The company's operating revenue for the third quarter was ¥561,436,258.30, representing a year-on-year increase of 37.65%[3] - The total profit for the year-to-date period was -¥270,564,227.20, indicating a significant decline compared to the previous year[3] - The net profit attributable to shareholders for the third quarter was -¥91,816,147.78, with a year-to-date net profit of -¥206,053,802.23[3] - Total operating revenue for the first three quarters of 2025 was ¥1,192,316,745.01, a decrease of 26.0% compared to ¥1,609,413,413.08 in the same period of 2024[17] - Net profit for the first three quarters of 2025 was a loss of ¥184,447,076.57, compared to a loss of ¥9,880,489.91 in the same period of 2024, representing a significant increase in losses[19] - The company reported a total profit loss of ¥270,564,227.20 for the first three quarters of 2025, compared to a loss of ¥78,169,791.47 in the same period of 2024[18] - The company’s total comprehensive loss for the first three quarters of 2025 was ¥184,447,076.57, compared to a loss of ¥9,880,489.91 in the same period of 2024[19] Earnings and Shares - The basic and diluted earnings per share for the third quarter were both -¥0.12, with year-to-date figures of -¥0.27[3] - Basic and diluted earnings per share for the first three quarters of 2025 were both -¥0.27, compared to -¥0.04 in the same period of 2024[19] Assets and Liabilities - Total assets at the end of the reporting period were ¥8,973,175,396.40, a decrease of 0.30% from the previous year-end[4] - The company's current assets totaled CNY 7,564,300,061.89, compared to CNY 7,670,852,916.65 in the previous year, indicating a decrease of approximately 1.4%[13] - The company's total liabilities stood at CNY 4,667,121,967.66, compared to CNY 4,509,251,711.74 in the previous year, indicating an increase of approximately 3.5%[15] - The total equity attributable to shareholders decreased to CNY 4,173,981,631.45 from CNY 4,377,345,421.73, reflecting a decline of about 4.6%[15] Cash Flow - The company reported a net cash flow from operating activities of -¥479,883,483.77 for the year-to-date period[3] - The net cash flow from operating activities for the first three quarters of 2025 was a negative ¥479,883,483.77, slightly worse than the negative ¥470,306,315.04 in the same period of 2024[21] - Cash inflow from investment activities was ¥2,883,832,890.38, an increase from ¥2,252,796,170.57 in the previous year[21] - The net cash flow from investing activities was $346,788,651.32, a significant improvement from a negative cash flow of $272,849,224.40 in the previous period[22] - Cash inflow from financing activities totaled $480,166,044.05, compared to $260,950,486.19 in the prior period, indicating a 84.1% increase[22] - The ending cash and cash equivalents balance increased to $522,407,642.13, up from $226,075,216.72 in the previous period[22] Shareholder Information - The company had a total of 49,436 common shareholders at the end of the reporting period[10] - The largest shareholder, Tianjin Zhibo Intelligent Technology Development Co., Ltd., holds 372,938,300 shares, accounting for 48.31% of total shares[10] - The company has no significant changes in shareholder relationships or actions, indicating stability in its ownership structure[11] Expenses - Total operating costs for the first three quarters of 2025 were ¥1,402,158,833.59, down 16.0% from ¥1,667,566,788.72 in the previous year[18] - Research and development expenses increased to ¥409,768,949.05, up 7.4% from ¥381,514,328.73 in the same period last year[18] Other Financial Metrics - Non-recurring gains and losses for the current period totaled ¥5,269,578.69, with year-to-date non-recurring gains and losses amounting to ¥22,340,916.50[6] - The company experienced a foreign exchange loss of $55,583.10, which was an improvement from a loss of $66,428.63 in the previous period[22] - Dividend payments decreased significantly to $21,588,562.99 from $69,546,018.18, reflecting a 68.9% reduction[22] Future Outlook - The company is set to implement new accounting standards starting in 2025, which may affect future financial reporting[23]

Financial Performance - The company's operating revenue for the third quarter was ¥968,030,190.84, a decrease of 32.58% compared to the same period last year[5] - The total profit for the quarter was ¥10,558,517.04, reflecting a significant decline of 79.37% year-over-year[5] - The net profit attributable to shareholders was ¥14,236,258.35, down 67.30% from the previous year[5] - The net profit after deducting non-recurring gains and losses was ¥12,192,230.62, a decrease of 72.01% compared to the same period last year[5] - The basic earnings per share for the quarter was ¥0.08, a decline of 75.47% year-over-year[6] - The diluted earnings per share also stood at ¥0.08, reflecting a 75.47% decrease compared to the previous year[6] - Total operating revenue for the first three quarters of 2025 is CNY 3,325,944,392.66, a decrease of 20.4% compared to CNY 4,178,040,229.74 in the same period of 2024[21] - Net profit for the first three quarters of 2025 is CNY 98,995,333.05, representing a decline of 21.8% from CNY 126,673,405.72 in the previous year[22] - Earnings per share for the first three quarters of 2025 is CNY 0.62, down from CNY 0.89 in the same period of 2024[22] Assets and Liabilities - Total assets increased by 19.00% to ¥3,572,656,921.02 compared to the end of the previous year[6] - Total assets as of September 30, 2025, reached CNY 3,572,656,921.02, an increase from CNY 3,002,311,105.56 as of December 31, 2024[16] - Total liabilities amount to CNY 1,688,917,640.70, an increase of 2.1% from CNY 1,641,989,052.83[18] - Total current liabilities were reported at CNY 1,043,000,000.00, compared to CNY 1,020,000,000.00 in the previous period[17] - The company has increased its long-term borrowings to CNY 222,551,631.16, up from CNY 177,588,335.12[18] - Short-term borrowings increased to CNY 252,853,687.58 from CNY 213,782,285.84, reflecting a rise of about 18.3%[17] Shareholder Information - The company has a total of 24,957 common shareholders at the end of the reporting period[13] - The top shareholder, Ganzhou Chengyou Investment Center, holds 9.26% of the shares, totaling 16,780,016 shares[13] - Total equity attributable to shareholders of the parent company is CNY 1,733,602,532.34, up 42.5% from CNY 1,216,098,225.16[18] Cash Flow - The net cash flow from operating activities for the year-to-date was ¥53,505,226.50, an increase of 178.70% compared to the same period last year[5] - In the first three quarters of 2025, the net cash flow from operating activities was ¥53,505,226.50, a significant improvement compared to a net outflow of ¥67,984,965.86 in the same period of 2024[24] - Total cash inflow from operating activities decreased to ¥2,429,890,457.68 in 2025 from ¥2,620,231,289.92 in 2024, reflecting a decline of approximately 7.3%[24] - Cash outflow for purchasing goods and services was ¥1,837,744,395.70, down from ¥2,193,731,842.44 in 2024, indicating a reduction of about 16.2%[25] - The net cash flow from investing activities was -¥364,415,763.32 in 2025, worsening from -¥157,328,069.26 in 2024[25] - Cash inflow from financing activities increased to ¥1,211,170,674.65 in 2025, compared to ¥796,164,052.80 in 2024, marking a growth of approximately 52%[25] - The net cash flow from financing activities improved to ¥510,847,189.85 in 2025 from ¥177,188,440.96 in 2024[25] - The ending cash and cash equivalents balance rose to ¥353,637,535.98 in 2025, up from ¥143,260,372.93 in 2024, reflecting a significant increase of approximately 147%[25] Research and Development - Research and development expenses for the first three quarters of 2025 are CNY 114,706,104.60, an increase of 25.6% compared to CNY 91,344,116.17 in the same period of 2024[21] Other Information - The company has not disclosed any significant new strategies or product developments during the reporting period[15] - The company reported a total of CNY 10,000,000.00 in trading financial assets, down from CNY 12,551,591.15[16] - Deferred income tax liabilities decreased to CNY 1,109,049.74 from CNY 1,296,264.70, reflecting a reduction of 14.5%[18] - Accounts receivable decreased to CNY 548,449,627.79 from CNY 600,184,931.54, indicating a reduction of approximately 8.6%[16] - Inventory remained stable at CNY 558,623,060.44, slightly increasing from CNY 558,509,001.31[16] - The impact of exchange rate changes on cash and cash equivalents was a positive ¥8,524,453.49 in 2025, compared to ¥14,827,872.27 in 2024[25]

Financial Performance - The company's operating revenue for the third quarter was ¥861,200,741.77, a decrease of 7.92% compared to the same period last year[4] - The total profit for the quarter was ¥147,025,590.32, reflecting a significant decline of 43.50% year-over-year[4] - The net profit attributable to shareholders was ¥129,054,853.21, down 42.39% from the previous year[4] - The basic earnings per share decreased by 46.67% to ¥0.08[5] - The company's total revenue for the first three quarters of 2025 was ¥2,277,546,584.52, a decrease of 5.43% compared to ¥2,408,402,297.08 in the same period of 2024[18] - Operating profit for the first three quarters of 2025 was ¥348,645,107.87, down 30.2% from ¥499,509,916.79 in the first three quarters of 2024[19] - Net profit for the first three quarters of 2025 was ¥295,864,839.28, a decline of 29.5% compared to ¥420,134,081.71 in the same period of 2024[19] - The company reported a basic earnings per share of ¥0.19 for the first three quarters of 2025, down from ¥0.27 in the same period of 2024[20] Assets and Liabilities - Total assets at the end of the period were ¥6,409,600,538.03, a decrease of 1.48% compared to the end of the previous year[5] - Total assets as of the end of the reporting period were ¥6,409,600,538.03, slightly down from ¥6,505,938,191.52 at the end of the previous year[16] - Total liabilities decreased to ¥937,578,236.37 from ¥1,194,743,587.97 in the previous year, indicating a reduction of approximately 21.5%[16] - The company’s total non-current assets amounted to ¥2,805,275,064.55, a decrease from ¥3,186,766,736.77 in the previous year[16] - The company's equity attributable to shareholders increased by 3.03% to ¥5,472,022,301.66[5] - The company’s total equity increased to ¥5,472,022,301.66 from ¥5,311,194,603.55, reflecting a growth of approximately 3.03%[16] Cash Flow - The cash flow from operating activities for the year-to-date was ¥645,889,944.63, down 48.52%[5] - The company's cash flow from operating activities for the first three quarters of 2025 was ¥645,889,944.63, a decrease of 48.5% from ¥1,254,600,890.69 in the first three quarters of 2024[22] - The company reported a significant outflow of ¥2,445,598,521.16 in the first three quarters of 2025, compared to ¥301,296,302.11 in the same period of 2024[22] - The net cash flow from investing activities was -$838.14 million, compared to -$295.96 million in the previous period[23] - The net cash flow from financing activities was -$149.65 million, down from -$172.36 million year-over-year[23] - The net increase in cash and cash equivalents was -$341.90 million, contrasting with an increase of $786.28 million in the prior period[23] - The ending balance of cash and cash equivalents was $707.04 million, significantly lower than $3.06 billion at the end of the previous period[23] Inventory and Receivables - Accounts receivable financing saw a 100% decrease, primarily due to the maturity of bank acceptance bills[9] - Inventory increased by 135.51%, mainly due to an increase in project reserve materials[9] - Accounts receivable increased to 669,444,622.69 from 539,860,520.36, indicating a rise in outstanding receivables[14] Expenses - R&D expenses for the current period were -100.00, primarily due to the absence of ongoing R&D projects[10] - Financial expenses increased by 54.59, attributed to optimized fund allocation and increased interest income[10] - Other income rose to 549.34, mainly due to the amortization of deferred income related to assets[10] - Investment income reached 121.29, driven by increased net profits from the associated company Chongqing Xinjianan Building Materials Co., Ltd.[10] - Total profit for the current reporting period was -43.50, primarily due to increased credit impairment losses[10] - Net profit attributable to shareholders for the current period was -42.39, reflecting an increase in credit impairment losses compared to the previous year[10] - Basic and diluted earnings per share for the current period were both -46.67, mainly due to increased credit impairment losses[10] - Cash flow from operating activities was -48.52, primarily due to a decrease in received energy efficiency payments[10] - The company reported a significant increase of 186.74% in taxes and surcharges, attributed to the absence of prior year's VAT refund adjustments[9]

新疆冠农股份有限公司 2025 年第三季度报告 证券代码：600251 证券简称：冠农股份 新疆冠农股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 公司董事会及董事、高级管理人员保证季度报告内容的真实、准确、完整，不存在虚假记载、 误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人刘中海、主管会计工作负责人金建霞及会计机构负责人（会计主管人员）罗雪妮 保证季度报告中财务信息的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、 主要财务数据 （一） 主要会计数据和财务指标 注："本报告期"指本季度初至本季度末 3 个月期间，下同。 1 / 10 单位：元 币种：人民币 项目 本报告期 本报告期比上年同期 增减变动幅度(%) 年初至报告期末 年初至报告期末比上年 同期增减变动幅度(%) 营业收入 301,821,864.79 -31.20 2,136,125,567.34 -24.80 利润总额 45,819,754.90 26.57 363,408 ...

振德医疗用品股份有限公司 2025 年第三季度报告 证券代码：603301 证券简称：振德医疗 振德医疗用品股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 公司董事会及董事、高级管理人员保证季度报告内容的真实、准确、完整，不存在虚假记载、误 导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息 的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、主要财务数据 （一） 主要会计数据和财务指标 单位：元 币种：人民币 | | | 本报告期比上 | | 年初至报告期末 | | --- | --- | --- | --- | --- | | 项目 | 本报告期 | 年同期增减变 | 年初至报告期末 | 比上年同期增减 | | | | 动幅度(%) | | 变动幅度(%) | | 营业收入 | 1,084,062,685.61 | 0.10 | 3,184,260,011.92 | 1. ...

Financial Performance - The company's operating revenue for the third quarter was ¥87,128,989.75, a decrease of 17.94% compared to the same period last year[4]. - The total profit for the third quarter was ¥2,963,104.90, down 75.40% year-on-year[4]. - The net profit attributable to shareholders was ¥4,445,704.84, reflecting a decline of 63.13% compared to the previous year[4]. - The net profit after deducting non-recurring gains and losses was ¥3,675,315.97, a decrease of 66.94% year-on-year[4]. - The basic earnings per share for the third quarter was ¥0.06, down 64.71% from the same period last year[5]. - Net profit for the first three quarters of 2025 was ¥8,577,528.63, a significant decline of 57.5% from ¥20,168,321.04 in 2024[20]. - Basic earnings per share for the first three quarters of 2025 was ¥0.12, down from ¥0.29 in the same period of 2024[21]. Cash Flow and Liquidity - The cash flow from operating activities showed a net outflow of ¥29,679,915.15 year-to-date, indicating challenges in cash management[4]. - Cash flow from operating activities for the first three quarters of 2025 was negative at -¥29,679,915.15, compared to -¥7,756,490.25 in 2024, indicating worsening cash flow conditions[22]. - Cash received from sales of goods and services was ¥193,048,493.70, a decrease of 14.2% from ¥225,020,021.41 in 2024[22]. - The ending balance of cash and cash equivalents was $389.12 million, down from $473.46 million in the previous period[23]. - The beginning balance of cash and cash equivalents was $502.46 million, indicating a decrease in liquidity[23]. Assets and Liabilities - Total assets at the end of the reporting period were ¥1,427,364,073.97, a slight decrease of 0.50% from the end of the previous year[5]. - The company's total current assets decreased from 1,092,095,892.24 to 1,005,898,195.00, a decline of approximately 7.93%[15][16]. - Total liabilities as of the reporting date were ¥412,842,239.70, slightly up from ¥409,208,411.59 in the previous year[17]. - Total equity attributable to shareholders was ¥1,011,696,649.81, a decrease from ¥1,024,132,445.61 in 2024, indicating a decline in shareholder value[17]. Research and Development - Research and development expenses totaled ¥13,023,155.11, a decrease of 2.19% year-on-year, accounting for 14.95% of operating revenue[5]. - Research and development expenses for the first three quarters of 2025 were ¥33,883,837.68, down from ¥36,822,923.74 in 2024, reflecting a potential shift in R&D focus[19]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 6,192[12]. - The largest shareholder, Wu Lihua, holds 12,510,000 shares, representing 17.46% of total shares[12]. Investment Activities - Net cash flow from investment activities was -$63.06 million, compared to -$28.80 million in the previous period, indicating a decline in investment performance[23]. - Total cash inflow from investment activities was $199.82 million, down from $626.62 million year-over-year[23]. - Cash outflow from investment activities totaled $262.88 million, a decrease from $655.42 million in the prior period[23]. Financing Activities - Net cash flow from financing activities was -$20.26 million, contrasting with a positive $6.74 million in the previous period[23]. - Total cash inflow from financing activities was $2.00 million, significantly lower than $7.38 million year-over-year[23]. - Cash outflow from financing activities amounted to $22.26 million, compared to $0.63 million in the prior period[23]. Other Information - The company experienced a significant reduction in government subsidies received compared to the previous year, impacting overall profitability[10]. - The company reported a credit impairment loss of ¥3,551,059.27 in 2025, contrasting with a gain of -¥3,572,084.20 in 2024, highlighting increased credit risk[20]. - The company will not apply new accounting standards starting from 2025[24].